Related Experiment Videos
[Molecular and clinical abnormalities of apolipoprotein A-I]
Insights
Low levels of high-density lipoprotein (HDL) cholesterol and its protein apolipoprotein A-I (apo A-I) are linked to increased coronary artery disease risk. Genetic factors influencing HDL and apo A-I may explain these risks.
Area of Science:
- Biochemistry
- Cardiovascular Science
- Genetics
Context:
- Epidemiological and clinical studies reveal a correlation between low high-density lipoprotein (HDL) cholesterol and apolipoprotein A-I (apo A-I) levels and coronary artery disease (CAD) risk.
- HDL cholesterol and apo A-I are crucial in reverse cholesterol transport, mediating cholesterol removal from peripheral cells to the liver.
Purpose:
- To explore the role of HDL-deficiency syndromes and apo A-I variants in determining coronary risk.
- To investigate if molecular defects in HDL and apo A-I directly cause low HDL cholesterol levels and elevate CAD risk.
Summary:
- Low plasma concentrations of HDL cholesterol and apo A-I are inversely correlated with the risk of developing coronary artery disease.
- Apo A-I is a key component of HDL, facilitating reverse cholesterol transport, a process vital for managing cholesterol levels.
- Genetic variations in HDL structure and function, including apo A-I variants and HDL-deficiency syndromes, serve as genetic markers for CAD risk.
Impact:
- Understanding the genetic basis of HDL cholesterol and apo A-I levels can identify individuals at higher risk for coronary artery disease.
- This research provides insights into the molecular mechanisms underlying CAD development.
- Genetic markers associated with HDL cholesterol metabolism could inform future diagnostic and therapeutic strategies for cardiovascular disease prevention.
Abstract:
Several epidemiological and clinical studies have shown an inverse correlation between low plasma concentration of high density lipoprotein (HDL) cholesterol as well as its major protein component, apolipoprotein A-I (apo A-I), and the risk of coronary artery disease. Apo A-I plays an important role in a reverse cholesterol transport. In this model, HDL mediates the cholesterol flux from peripheral cells to the liver. The structure and function of HDL-deficiency syndromes and apo A-I variants provides genetic markers of whether the presence of these molecular defects accounts for low HDL cholesterol levels and the coronary risk.